Global Breast Cancer Screening Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Breast cancer screening is the medical screening of asymptomatic, apparently healthy women for breast cancer in an attempt to achieve an earlier diagnosis. 
A number of screening tests have been employed, including clinical and self-breast exams, mammography, genetic screening, ultrasound, and magnetic resonance imaging.
According to our (Global Info Research) latest study, the global Breast Cancer Screening market size was valued at USD 49 million in 2022 and is forecast to a readjusted size of USD 85 million by 2029 with a CAGR of 8.0% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Breast Cancer Screening key players include Hologic, GE Healthcare, Siemen Healthineers, etc. Global top three manufacturers hold a share about 65%.
North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, both have a share about 40 percent. 
In terms of product, Mammography Screening is the largest segment, with a share about 70%. And in terms of application, the largest application is Hospital, followed by Clinic.
This report is a detailed and comprehensive analysis for global Breast Cancer Screening market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Breast Cancer Screening market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K USD/Unit), 2018-2029
Global Breast Cancer Screening market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K USD/Unit), 2018-2029
Global Breast Cancer Screening market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K USD/Unit), 2018-2029
Global Breast Cancer Screening market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Breast Cancer Screening
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Breast Cancer Screening market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hologic, GE Healthcare, Siemen Healthineers, Philips Healthcare and Canon Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Breast Cancer Screening market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    Mammography Screening
    Breast Magnetic Resonance Imaging (MRI) Screening
    Breast Ultrasound Screening
Market segment by Application
    Hospital
    Clinic
Major players covered
    Hologic
    GE Healthcare
    Siemen Healthineers
    Philips Healthcare
    Canon Medical
    Fujifilm
    Metaltronica
    Sino Medical-Device
    IMS Srl
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Breast Cancer Screening product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Breast Cancer Screening, with price, sales, revenue and global market share of Breast Cancer Screening from 2018 to 2023.
Chapter 3, the Breast Cancer Screening competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Breast Cancer Screening breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Breast Cancer Screening market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Breast Cancer Screening.
Chapter 14 and 15, to describe Breast Cancer Screening sales channel, distributors, customers, research findings and conclusion.